Gebauer, Florian http://orcid.org/0000-0001-5312-4814
Krämer, Max
Bruns, Christiane
Schlößer, Hans A.
Thelen, Martin
Lohneis, Philipp
Schröder, Wolfgang
Zander, Thomas
Alakus, Hakan
Buettner, Reinhard
Loeser, Heike
Quaas, Alexander
Article History
Received: 26 April 2020
Accepted: 20 June 2020
First Online: 26 June 2020
Compliance with ethical standards
:
: Reinhard Büttner: Co-Founder and Co-Owner of Targos Molecular Pathology Inc. Kassel/Germany. Hans Schlösser: Funding for Research from Astra Zeneca for research outside this study. Thomas Zander: BMS: advisory board, clinical trial; Novartis: advisory board, clinical trial; Lilly: advisory board, clinical trial; MSD: advisory board, clinical trial. The remaining authors declare no conflict of interest or other financial disclosures.
: The study was approved by the local ethics committee, due to the anonymised character of the study, individual consent of the patients was not requested.